Abstract:Objective To discuss the efficacy and safety of Tranexamic acid (TXA) in reducing the perioperative blood loss of total hip arthroplasty by different ways of administration. Methods Forty patients undergoing unilateral total hip arthroplasty were randomly assigned to three groups. In group A (n = 12), TXA was injected locally into joint cavity. In group B (n = 14), TXA was intravenous infused combined with locally injection in joint cavity. In group C (n = 14), TXA was intraoperatively locally sprayed combined withlocally injected in joint cavity. The dominant blood loss, occult blood loss, blood transfusion rate, average transfusion volume, coagulation function and thrombotic complications were compared among the groups. Results The preoperative general data, hospital stay, blood transfusion rate, preoperative HGB content and complication rate were not significantly different in three groups (P > 0.05). The blood loss and average transfusion volume in group C were significantly lower than those in group A and group B (P < 0.05), while there was no significant difference between group A and group B (P > 0.05). The level of HGB in three groups was significantly lower than that before operation (P < 0.05). The level of HGB in group C was significantly higher than that in group A and B (P < 0.05). There were no significant differences for DD, FIB, PT and APTT in three groups before and after operation (P > 0.05). The content of FIB in three groups was significantly lower than that before operation, and APTT was significantly longer (P < 0.05). Conclusion Local medication is better than intravenous administration, and it can reduce the perioperative bleeding of total hip replacement safely and effectively.